相关临床试验
1
1 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
N/A
进行中（未招募）
1
100.0%
暂无批准数据
- A 41-year-old woman with stage IV bowel cancer experienced a dramatic turnaround after receiving an intrathecal morphine pump at Derriford Hospital in Plymouth, moving from palliative care to a "completely normal" life. - The surgically implanted pump delivers tiny amounts of morphine directly into the spine, providing targeted pain relief while eliminating systemic side effects associated with oral or intravenous opioids. - Nurse consultant Lindsey Pollard reported that 25 patients have received the device through the service, with many experiencing life-changing results including returning to work and daily activities. - Anaesthetist Dr David Hutchins cautioned the treatment is suitable for "very few patients" but can "change people's lives dramatically," as the service expands into a new dedicated facility at Plymouth Marjon University.
- Brian Holmes, a 70-year-old patient at Derriford Hospital in Plymouth, became the first person in the UK and fifth globally to receive an experimental antibody drug conjugate treatment for metastatic prostate cancer. - The pioneering treatment combines monoclonal antibodies with chemotherapy agents to deliver targeted therapy directly to cancer cells while sparing healthy tissue. - Holmes had exhausted all other treatment options over two years since his diagnosis, making this clinical trial his only hope to extend his life expectancy. - While antibody drug conjugates are currently used in the NHS for other cancers like breast cancer, they are not available for prostate cancer treatment outside of clinical trials.
